by Sue Robbins | Nov 20, 2019 | Migraine
Intranasal lidocaine may be a useful option for patients with an acute migraine, according to a study which showed the drug had a high success rate, low pain intensity, infrequent need for rescue medicine, and tolerable adverse events. The research, published by PLOS...
by Sue Robbins | Nov 19, 2019 | Migraine
Migraine sufferers who used a smartphone-based relaxation technique at least twice a week experienced on average four fewer headache days per month, a new study shows. Developed in part by researchers at NYU School of Medicine, the app, called RELAXaHEAD, guides...
by Sue Robbins | Nov 14, 2019 | Migraine
I’ve been fighting the pain of chronic migraines for years. I’ve become a master at dealing with the debilitating side effects that go along with these crippling headaches: lack of appetite, insomnia, mood swings–don’t even get me started on all the...
by Sue Robbins | Nov 8, 2019 | Migraine
Eli Lilly, Allergan and Biohaven have a lot riding on their forthcoming migraine launches, and now cost-effectiveness watchdog ICER has come out with some less-than-stellar findings from data supporting the drugs. The Institute for Clinical and Economic...
by Sue Robbins | Nov 7, 2019 | Miscellaneous
Migraines are a common type of headache disorder affecting approximately 20% of women and 7% of men. Due to the potentially debilitating symptoms experienced, research continues to investigate etiology, including the impact of body posture. What are migraines?...
